Latest news and articles about revenue growth from NEX English
Marvel Semiconductor has announced that revenue growth is expected to continue accelerating in the upcoming quarters. This comes amid exceptional demand for artificial intelligence technologies, reflecting the strength of the market in this sector.
Palantir Technologies has announced its fastest revenue growth ever, fueled by a significant increase in demand in the US market. This comes at a time when the artificial intelligence sector is experiencing remarkable development, highlighting the company's importance in this field.
The National Mobile Telecommunications Company announced its financial results for the third quarter of the year, showing significant growth in revenues and profits despite economic challenges in the market.
Equifax announced its fastest revenue growth in over four years, driven by a significant increase in mortgage applications. This growth reflects a recovery in the housing market and indicates an improvement in economic activity.
DIEZ, based in Dubai, announced a significant revenue growth of <strong>19.4%</strong> in 2025, along with a <strong>17.8%</strong> increase in profits. This growth occurs amid a notable recovery in the UAE market.
Analysts predict that Alibaba's cloud and artificial intelligence sectors will be key growth drivers in the upcoming quarter, with revenue growth expected to reach around <strong>40%</strong> due to increased investment in AI and business restructuring.
Response Plus Holding has announced a significant revenue growth of <strong>13%</strong>, reaching <strong>516 million AED</strong> by <strong>2025</strong>. This growth reflects the company's ambitious strategies for expansion and market growth.
DCI Indonesia announced a revenue of <strong>2.5 trillion Indonesian rupiah</strong> in 2025, marking a significant increase of <strong>40.1%</strong> compared to the previous year. This growth is attributed to the operation of the new <strong>JK6 data center</strong> and an expanded customer base.
Hua Medicine, a leading Chinese biotechnology firm, announced a remarkable revenue growth of <strong>93%</strong> for 2026. In an exclusive interview with Bloomberg's 'China' program, Strategic Director George Lin discussed the prospects of the company's main drug, Duzaglitin, and plans for expansion into new markets.